Head-to-head · Cost-Efficiency Index
Wisp vs Chia
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Wisp
Shoppers who want brand-name injectables with a sublingual semaglutide option.
Visit WispChia
Shoppers who want month-to-month GLP-1 care with a money-back guarantee, and who will compare the committed-plan discount against its early-cancellation math.
Visit ChiaThe verdict
Wisp and Chia tie on the Cost-Efficiency Index at 63/100, so neither wins outright on the numbers, so choose on fit. Wisp: Shoppers who want brand-name injectables with a sublingual semaglutide option. Chia: Shoppers who want month-to-month GLP-1 care with a money-back guarantee, and who will compare the committed-plan discount against its early-cancellation math.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Wisp.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Wisp | Chia |
|---|---|---|
| Cost-Efficiency Index | 63/100 | 63/100 |
| Semaglutide / mo | $225/moCompounded oral | $349/moMonth to month, compounded; $249/mo on a committed multi-month plan |
| Tirzepatide / mo | Not disclosed | $399/moMonth to month, compounded; from $249/mo on a committed multi-month plan |
| Semaglutide / yr (modeled) | $2,700 | $4,188 |
| Tirzepatide / yr (modeled) | — | $4,788 |
| Coverage | Coverage not published | Not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #248 | #250 |
Wisp
63/100Where the value is
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
The tradeoffs
- The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
- The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
Chia
63/100Where the value is
- Month-to-month plans carry a 30-day money-back guarantee for first-time weight-loss customers
- Both the committed-plan figure and the month-to-month figure appear on the product page before the quiz
- Offers a daily tirzepatide tablet as well as weekly injections
The tradeoffs
- The "Starting from $249.00/mo" headline is a committed 3-, 4- or 6-month plan price; month to month is $349 for semaglutide and $399 for tirzepatide
- Cancel a committed plan early and your refund is recalculated at the full monthly rate for the months you used, which can leave nothing back
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.